Prehabilitation before gynecologic surgery may speed recovery
NCT ID NCT07188662
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tested whether a multimodal prehabilitation program (exercise, nutrition, and education before surgery) could improve outcomes for 140 women undergoing gynecologic cancer surgery. The program was combined with enhanced recovery after surgery (ERAS) care. Researchers measured complications, pain, and hospital stay length within 30 days after surgery.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- multimodal prehabilitation program (exercise, nutrition, and education before surgery)
- What this could lead to
- If it works, this program could help women recover faster and with fewer complications after gynecologic cancer surgery.
- What could go wrong
- This is a small, completed study with no phase designation, so results may not apply to all patients. The program requires extra time and effort before surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GYNECOLOGIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Woman's Health Hospital
Asyut, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized exercise program boost recovery in cancer survivors?
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- Braids and conditioner may boost scalp cooling against chemo hair loss
- New imaging tool could help surgeons detect hidden cancer cells during surgery
- Could an ALS drug clear the fog of chemo brain?
- Could a chatbot help close the gap in genetic cancer testing?